Nadejda Tsankova

Professor

Icahn School of Medicine at Mount Sinai

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Nadejda Tsankova is a faculty member at the Icahn School of Medicine at Mount Sinai in the United States. Her research focuses on neuro-oncology, specifically gliomas and astrocytomas, with recent publications addressing genetic alterations and tumor microenvironments. She explores innovative diagnostic techniques and therapeutic approaches, particularly in the context of cancer treatment and immune response.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (7)

Nicola Jayne Robertson

University College London

UNITED KINGDOM

View details

Roland Friedel

Associate Professor

Icahn School of Medicine at Mount Sinai

UNITED STATES

View details

Philip Empey

University of Pittsburgh

UNITED STATES

View details

Chang Wang

Assistant Professor

University of Oklahoma

UNITED STATES

View details

Vivek S Yedavalli

Johns Hopkins University

UNITED STATES

View details

Michael Talkowski

Professor

Massachusetts General Hospital

UNITED STATES

View details

James Ross

Assistant Professor

University of Virginia

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nadejda Tsankova

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

EGFR alteration is an adverse prognostic factor in IDH-mutant astrocytoma.

Spatial Multi-omics Defines a Shared Tumor Infiltrative Signature at the Resection Margin in High-Grade Gliomas.

An expanded subventricular zone supports postnatal cortical interneuron migration in gyrencephalic brains

Glioblastoma shift from bulk to infiltrative growth is guided by plexin-B2-mediated microglia alignment in invasive niches

LNP-RNA-mediated antigen presentation leverages SARS-CoV-2-specific immunity for cancer treatment

Multiparametric Radiogenomic Model to Predict Survival in Patients with Glioblastoma

A common flanking variant is associated with enhanced stability of the FGF14-SCA27B repeat locus

Genetic and epigenetic instability as an underlying driver of progression and aggressive behavior in IDH-mutant astrocytoma

In situ brain tumor detection using a Raman spectroscopy system—results of a multicenter study

Microglia and monocyte-derived macrophages drive progression of pediatric high-grade gliomas and are transcriptionally shaped by histone mutations

Collaborators (7)

Nicola Jayne Robertson

Roland Friedel

Philip Empey

Chang Wang

Vivek S Yedavalli

Michael Talkowski

James Ross

Make your next move.